Intellectual property related to the Australian Life Sciences sector

Compiled by Stuart Roberts, Senior Analyst, stuart@ndfresearch.com, +61 447 247 909

The World Intellectual Property Organisation publishes new PCT patent applications every Thursday. Australian applicants generally have 12 or 13 healthcare and biotech-related patent applications published each month while New Zealand applicants have two or three a month.

Australian applications

Here are the 451 PCT patent applications relevant to Australia's Life Sciences sector that have published since the start of 2014, for a publication rate of 12.6 applications per month:

WO/2016/205892, Composition for the prevention of microbial growth, Eikonic R&D, 29 December 2016
WO/2016/205853, Packaged silicone lubricated condom that provides sensation, Ansell, 29 December 2016
WO/2016/201528, Treatment of inflammation and/or cancer, Queensland Institute of Medical Research, 22 December 2016
WO/2016/201524, Metal ion complexes, RR Medsciences Pty Ltd, 22 December 2016
WO/2016/201519, Method of treating Crohn's disease, Murdoch Childrens Research Institute, 22 December 2016
WO/2016/201506, A skin-care composition and kit for and method of producing it, Deborah Riddle, 22 December 2016
WO/2016/201503, IL-37 variants, Monash University, 22 December 2016
WO/2016/201481, Pharmaceutical combinations of organo-arsenoxide compounds and MTOR inhibitors, NewSouth Innovations, 22 December 2016
WO/2016/198507, Aryl sulfonohydrazides, Monash University, 15 December 2016
WO/2016/198072, Antiviral conjugates of polyanionic polymer and antiviral drug, CSIRO with Aarhus Universitet (Denmark), 15 December 2016
WO/2016/197878, Pharmaceutical composition for treatment of menopausal syndrome and preparation method thereof, Thisherb Health Pty Ltd, 15 December 2016
WO/2016/197877, Pharmaceutical composition for treatment of depression and preparation method thereof, Thisherb Health Pty Ltd, 15 December 2016
WO/2016/197204, Pharmaceutical combination and uses thereof, Bionomics, 15 December 2016
WO/2016/197196, A method of treatment, Prince Henry's Institute of Medical Research, 15 December 2016
WO/2016/197190, Structure of Plasmepsin V in complex with an inhibitor and uses thereof, Walter and Eliza Hall Institute of Medical Research, 15 December 2016.
WO/2016/191820, Formulation and process for limiting nerve trauma, NewSouth Innovations, 8 December 2016
WO/2016/191816 Glucose sensitive phenylborate acid capsules for insulin delivery, University of Melbourne, 8 December 2016
WO/2016/191814, Methods and products for enriching and isolating stem cells, Adelaide Research & Innovation, 8 December 2016
WO/2016/191811, Mobilizing agents and uses therefor, University of Queensland, 8 December 2016
WO/2016/191790, A method of in vivo treatment, Hexima, 8 December 2016
WO/2016/187667, Functionalised and substituted indoles as anti-cancer agents, Novogen, 1 December 2016
WO/2016/187666, Antibacterial bismuth complexes, Monash University, 1 December 2016
WO/2016/187643, Composition and uses thereof, Aroborvitae Health and Wellbeing, 1 December 2016
WO/2016/187151, Methods of discriminating between HIV-1 and lentiviral vectors, Calimmune, 24 November 2016
WO/2016/186708, Gene therapeutic for the treatment of HIV and uses thereof, Calimmune, 24 November 2016
WO/2016/183634, Skin exfoliant composition, SNDR, 24 November 2016
WO/2016/183633, Skin cleansing composition, SNDR, 24 November 2016
WO/2016/183630, Skin moisturizing composition, SNDR, 24 November 2016
WO/2016/179657, Amino acid supplementation, Newcastle Innovation, 17 November 2016
WO/2016/179645, 4H-pyran compounds as Insulin-Regulated Aminopeptidase (IRAP) inhibitors, Monash University, Florey Institute of Neuroscience and Mental Health and St. Vincent's Institute of Medical Research, 17 November 2016
WO/2016/179639, Probiotic compositions and uses thereof, Ro Markson, 17 November 2016
WO/2016/176745, Reagents for treatment of Hepatitis B Virus (HBV) infection and use thereof, Benitec Biopharma, 10 November 2016
WO/2016/176729, Bacteriocin polypeptides and uses thereof, RMIT University, 10 November 2016
WO/2016/176437, Targeting NAD+ to treat chemotherapy and radiotherapy induced cognitive impairment, neuropathies and inactivity, NewSouth Innovations, 3 November 2016
WO/2016/172769, Compositions and methods for administering antibodies, University of South Australia, 3 November 2016
WO/2016/172766, Method for production of heparin and heparan sulfate, NewSouth Innovations, 3 November 2016
WO/2016/172762, Schistosomiasis vaccine, James Cook University, 3 November 2016
WO/2016/172703, Kappa myeloma antigen chimeric antigen receptors and uses thereof, Haemalogix, 27 October 2016
WO/2016/172608, SMAD7 gene delivery as a therapeutic, Baker IDI Heart and Diabetes Institute with Washington State University, 27 October 2016
WO/2016/168897, Pharmaceutical powder composition and its use in the control of post-prandial glycaemic profile, Omniblend Innovation, 27 October 2016
WO/2016/168890, Generation of muscle-lineage cells from stem cells, Genea Biocells, 27 October 2016
WO/2016/168885, Therapeutic antibodies and uses thereof, Minomic International, 27 October 2016
WO/2016/164980, A vaccine composition and uses thereof, Imugene, 20 October 2016
WO/2016/164977, A method of treatment, Prince Henry's Institute of Medical Research, 20 October 2016
WO/2016/161477, A method of treating neoplasias, Prince Henry's Institute of Medical Research, 13 October 2016
WO/2016/154684, Agents and compositions for eliciting an immune response, Cancure, 6 October 2016
WO/2016/154683, Pain treatment, Biosceptre, 6 October 2016
WO/2016/154682, Method for predicting risk of cognitive deterioration, CRC for Mental Health, 6 October 2016
WO/2016/154665, Handling of biological samples, Genea, 6 October 2016
WO/2016/149771, Streptococcal vaccine, Gamma Vaccines, 29 September 2016
WO/2016/149765, Sodium channel modulators, Florey Institute of Neuroscience and Mental Health, 29 September 2016
WO/2016/149756, Treatment of respiratory diseases, University of Melbourne, 29 September 2016
WO/2016/145488, Treatment of skin conditions, Monash University, 22 September 2016
WO/2016/145479, Compositions for the treatment of fibrosis and fibrosis-related conditions, Vectus Biosystems, 22 September 2016
WO/2016/145478, Compositions for the treatment of kidney and/or liver disease, Vectus Biosystems, 22 September 2016
WO/2016/141441, Treatment and detection of inflammatory disease, Queensland Institute of Medical Research, 15 September 2016
WO/2016/141413, Drug delivery composition comprising polymer-lipid hybrid microparticles, University of South Australia, 15 September 2016
WO/2016/138569, Method of treatment of central neuropathic pain, University of Queensland, 9 September 2016
WO/2016/138559, Combination treatment protocol, Bionomics, 9 September 2016
WO/2016/138558, Methods for adversely affecting biofilms, Commonwealth Scientific and Industrial Research Organisation with Monash University, 9 September 2016
WO/2016/138534, Antisense-induced exon2 inclusion in acid alpha-glucosidase, Sarepta Therapeutics with Murdoch University, 1 September 2016
WO/2016/137010, Anti cancer agent comprising aminoacetonitrile compound as active ingredient, Nihon Nohyaku Co. with Pitney Pharmaceuticals (owned by PharmAust), 1 September 2016
WO/2016/134422, A method of treatment, Hudson Institute of Medical Research, 1 September 2016
WO/2016/131100, Methods of treating infectious diseases, Walter and Eliza Hall Institute of Medical Research, 25 August 2016
WO/2016/131098, Sulfonylureas and related compounds and use of same, University of Queensland, 25 August 2016
WO/2016/127221, Analgesic formulation, Angelo Pricolo, 18 August 2016
WO/2016/127216, EpCAM aptamers and conjugates thereof, Deakin University, 18 August 2016
WO/2016/127213, Inhibitors of necroptosis, Catalyst Therapeutics, 18 August 2016
WO/2016/126878, Listeria-based immunomodulation, University of Pennsylvania and Peter MacCallum Cancer Centre, 11 August 2016
WO/2016/123679, A method of treatment, Petranel Ferrao, 11 August 2016
WO/2016/123675, Targeting constructs for delivery of payloads, University of Queensland, 11 August 2016
WO/2016/123672, A method of treatment and compounds for use therein, Baker IDI Heart & Diabetes Institute, 11 August 2016
WO/2016/123670, Ruthenium and indium binding to gastrins, Eupharma, 11 August 2016
WO/2016/123659, A composition and formulation of pine bark extract (PBE) for providing health benefits, Plasmaide, 11 August 2016
WO/2016/123650, Methods and compositions for extending reproductive life using beta-cryptoxanthin, University of South Australia, 11 August 2016
WO/2016/119023, Therapeutic and diagnostic agents, Nexvet, 4 August 2016
WO/2016/119019, Compositions containing arsenic and their use in methods of treatment, Eupharma, 4 August 2016
WO/2016/119017, Anti-cancer compounds, University of Sydney, 4 August 2016
WO/2016/119004, Novel, heavy Vitamin B12 derivatives, Charles Sturt University, 4 August 2016
WO/2016/109872, CXCR4 binding molecules, Adalta, 14 July 2016
WO/2016/101041, Mineralization fluoride compositions, University of Melbourne, 30 June 2016
WO/2016/101028, Formulation and method of use, Sanofi Consumer Healthcare Australia, 30 June 2016
WO/2016/101025, Compositions and methods for injectable composition for an accommodating intraocular lens, Brien Holden Vision Institute, 30 June 2016
WO/2016/101024, Method of treatment, Baker IDI Heart & Diabetes Institute, 30 June 2016
WO/2016/097773, Therapeutic IAP antagonists for treating proliferative disorders, Children's Cancer Institute, 23 June 2016
WO/2016/094962, Il-21 antibodies, Monash University, 23 June 2016
WO/2016/090434, Dislodgement and release of HSC using alpha 9 integrin antagonist and CXCR4 antagonist, Commonwealth Scientific and Industrial Research Organisation, 16 June 2016
WO/2016/090404, Methods and compositions for treating or preventing flavivirus infections, University of Queensland, 16 June 2016
WO/2016/090403, Dislodgement and release of HSC from the bone marrow stem cell niche using alpha9 integrin antagonists, Commonwealth Scientific and Industrial Research Organisation, 16 June 2016
WO/2016/086261, 4H-Pyrido[1,2-A]Pyrimidin-4-one compounds, Prana Biotechnology, 9 June 2016
WO/2016/081993, Methods for the treatment and prevention of asbestos-related diseases, University of Technology, Sydney, 2 June 2016
WO/2016/077885, Fragrant nail polish, Pure Euphoria, 26 May 2016
WO/2016/077884, Topical composition, SNDR, 26 May 2016
WO/2016/077879, Copolymer and method for treatment of bacterial infection, Recce, 26 May 2016
WO/2016/077878, Method of treating or preventing stroke, CSL Ltd, 26 May 2016
WO/2016/074033, Tumour Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL): Compositions and methods for treating wound healing, Heart Research Institute, 19 May 2016
WO/2016/070241, Triazine compounds, compositions and synthesis, CTXT, 12 May 2016
WO/2016/065426, Detection and treatment of excessive hair shedding, Samson Clinical, 6 May 2016
WO/2016/065419, Treatment for depression and depressive disorders, Medlab, 6 May 2016
WO/2016/065410, Use of therapeutic agents, Walter and Eliza Hall Institute of Medical Research, 6 May 2016
WO/2016/065409, Interferon Α2B variants, Teva Pharmaceuticals Australia, 6 May 2016
WO/2016/063269, Use of antagonists to the nuclear steroid receptor alone or in combination as direct antiviral agents to inhibit alphavirus, togaviridae, arenaviridae, filoviridae, bunyaviridae, flaviviridae and rhabdoviridae, Patrick Prendergast, 28 April 2016
WO/2016/061632, FN14-binding proteins and uses thereof, La Trobe University, 28 April 2016
WO/2016/061623, A method of treatment, University of Melbourne, 28 April 2016
WO/2016/061619, A method of treatment, Hexima, 28 April 2016
WO/2016/061618, Selective targeting of procoagulant platelets, Newsouth Innovations, 28 April 2016
WO/2016/061617, CD83 binding proteins and uses thereof, Dendrocyte Biotech, 28 April 2016
WO/2016/061615, Methods of reducing mammographic breast density and/or breast cancer risk, Chavah, 28 April 2016
WO/2016/061611, Improved clotting composition, Q-Sera, 28 April 2016
WO/2016/061608, Monoclonal anti-GPC-1 antibodies and uses thereof, Minomic International, 28 April 2016
WO/2016/058057, Improved cosmetic and personal care products from legumes, Blue Ribbon Roasting, 21 April 2016
WO/2016/058056, Novel imaging composition and uses thereof, University Of Melbourne, 21 April 2016
WO/2016/058047, Improved midkine antibody, Cellmid, 21 April 2016
WO/2016/054696, Chimeric proteins, Lipotek, 14 April 2016
WO/2016/054680, Modulators of 14-3-3 functionality and uses thereof, University Of South Australia, 14 April 2016
WO/2016/054671, Selenosugars and therapeutic uses thereof, Carl Schiesser, 14 April 2016
WO/2016/051389, Enhanced loading of intact, bacterially derived vesicles with small molecule compounds, EnGeneIC, 7 April 2016
WO/2016/049705, Therapeutic compositions and methods for inducing an immune response to Herpes Simplex Virus Type 2, Admedus, 7 April 2016
WO/2016/049700, Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders, Lachesis Biosciences, 7 April 2016
WO/2016/049677, Method of treating cancer, Walter and Eliza Hall Institute of Medical Research, 7 April 2016
WO/2016/041014, Treatment of tumours using peptide-protein conjugates, University of Western Australia, 24 March 2016
WO/2016/041013, Glycerolipids and uses therefor, Baker IDI Heart And Diabetes Institute, 24 March 2016
WO/2016/040987, Treating and/or preventing psoriasis, Abregen, 24 March 2016
WO/2016/037240, Immunological reagent, University of Melbourne, 17 March 2016
WO/2016/035052, Anti-nerve growth factor antibodies for treating itching, Nexvet, 10 March 2016
WO/2016/034675, Tetrahydroisoquinoline derived PRMT5-Inhibitors, CTXT, 10 March 2016
WO/2016/034673, Tetrahydroisoquinoline derived PRMT5-inhibitors, CTXT, 10 March 2016
WO/2016/034671, Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors, CTXT, 10 March 2016
WO/2016/033660, Antiviral agents and uses thereof, Griffith University, 10 March 2016
WO/2016/033643, Methods for treatment and prevention of vascular disease, Gemma Figtree, 10 March 2016
WO/2016/033635, Methods for treating protozoan infections, Neoculi, 10 March 2016
WO/2016/029275, Treatment of HIV, Newsouth Innovations, 3 March 2016
WO/2016/029267, A method for culturing mesenchymal stem cells, Hudson Institute of Medical Research, 3 March 2016
WO/2016/029263, MAPK inhibitors, Bing Wang 3 March 2016
WO/2016/029262, Compositions for modulating cancer stem cells and uses therefor, University Of Canberra, 3 March 2016
WO/2016/025977, Capsaicinoids and uses thereof as medicaments, Mandishora Muzari, 25 February 2016
WO/2016/025747, Nonlinear copolymers as intracellular delivery vehicles and related methods, Almar Postma and John Chiefari for the CSIRO, with John Wilson of Vanderbilt University and Anthony Convertine and Patrick Stayton of the University of Washington, 18 February 2016
WO/2016/025339, Methods and materials for activating an internal ribosome entry site in exon 5 of the DMD gene, Nationwide Children's Hospital (US), University of Western Australia, 18 February 2016
WO/2016/023082, Lymph directing prodrugs, Monash University, 18 February 2016
WO/2016/023072, Novel potassium channel blockers and use thereof in the treatment of autoimmune diseases, Monash University, 18 February 2016
WO/2016/020210, Factor VIII formulation, CSL Ltd, 11 February 2016
WO/2016/015095, A method for the identification of immunotherapy-drug combinations using a network approach, University of Western Australia, 4 February 2016
WO/2016/015094, Topical composition, Acrux, 4 February 2016
WO/2016/011511, Bacillus Amyloliquefaciens probiotic compositions, methods of production, and methods of use, The University Of Queensland, 28 January 2016
WO/2016/011501, Constrained proteins and uses therefor, Monash University, 28 January 2016
WO/2016/011498, Compositions and methods of use, Melcare Medical, 28 January 2016
WO/2016/011496, Treatment and prevention of the common cold using povidone-iodine, Firebrick Pharma, 28 January 2016
WO/2016/011487, Antagonistic peptides, Deakin University, 28 January 2016
WO/2016/008011, Functionalised and substituted indoles as anti-cancer agents, Novogen, 21 January 2016
WO/2016/008010, Functionalised and substituted carbazoles as anti-cancer agents, Novogen, 21 January 2016
WO/2016/008005, Galectin immunotherapy, Queensland Institute of Medical Research, 21 January 2016
WO/2016/007993, Benzene sulfonamide-based inhibitors of sphingosine kinase, University of South Australia, 21 January 2016
WO/2016/001907, Mogroside IV and Mogroside V as agonist/stimulator/un-blocking agent for Toll-Like Receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents, Patrick Prendergast, 7 January 2016
WO/2016/000039, Modified Von Willebrand Factor, CSL Ltd, 7 January 2016
WO/2016/000032, Host-guest metal organic framework systems, Commonwealth Scientific and Industrial Research Organisation, 7 January 2016
WO/2016/000022, Helicobacter therapeutic, Murdoch Childrens Research Institute, 7 January 2016
WO/2016/000012, Predicting response to cancer therapy, Bionomics, 7 January 2016
WO/2015/196258, Enzyme interacting agents, Monash University, 30 December 2015
WO/2015/196250, Lipid comprising docosapentaenoic acid, Commonwealth Scientific and Industrial Research Organisation, 30 December 2015
WO/2015/196245, Modulation of osteogenesis and or angiogenesis by modulating peroxidase functionality, Adelaide Research & Innovation, 30 December 2015
WO/2015/191799, Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof, Bionomics with Merck & Co., 17 December 2015
WO/2015/191595, A novel formulation of meloxicam, Iceutica, 17 December 2015
WO/2015/188235, Dietary supplement, Gratuk Technologies, 17 December 2015
WO/2015/188223, Device and method to treat or prevent joint degeneration, International Scientific, 17 December 2015
WO/2015/184510, Dendrimer-drug conjugates, Starpharma, 10 December 2015
WO/2015/184509, Methods of treating neurodevelopmental diseases and disorders, Deakin University, 10 December 2015
WO/2015/184494, Process for preparation of caffeine extract, Abroad Promotions, 10 December 2015
WO/2015/181641, Combination of lenalidomide or pomalidomide and CD38 antibody-attenuated interferon-alpha constructs, and the use thereof, Teva Pharmaceuticals Australia, 3 December 2015
WO/2015/179918, Modulation of cellular stress, University of Queensland, 3 December 2015
WO/2015/179893, A therapeutic protocol for treating ovarian cancer, Bionomics, 3 December 2015
WO/2015/176135, Omega-3 analogues, University of Sydney, 26 November 2015
WO/2015/176104, Bak binding proteins, Walter and Eliza Hall Institute of Medical Research, 26 November 2015
WO/2015/172203, Methods for inhibiting necroptosis, Catalyst Therapeutics, 19 November 2015
WO/2015/172196, Heterocyclic compounds and use of same, Monash University, 19 November 2015
WO/2015/172191, Probiotic compositions and uses thereof for treatment of obesity-related disorders, Medlab, 19 November 2015
WO/2015/168741, Extended shelf life wound healing formulation, Mark Deacon-Shaw, 12 November 2015
WO/2015/168726, Method for treating renal cell carcinoma, Sirtex Medical, 12 November 2015
WO/2015/161348, Agents and methods of treatment, Hexima, 29 October 2015
WO/2015/161346, Agents and methods for treatment of pathogens, Hexima, 29 October 2015
WO/2015/159103, Piperazine derivatives for treating disorders, University of Nottingham and Newsouth Innovations, 22 October 2015
WO/2015/157829, Modified relaxin B chain peptides, Florey Institute Of Neuroscience And Mental Health, 22 October 2015
WO/2015/157820, Group A streptococcus vaccine, Griffith University, 22 October 2015
WO/2015/157794, Compositions and methods for the treatment or prevention of neurodegenerative disorders, Northern Sydney Local Health District, 22 October 2015
WO/2015/154141, Methods and compositions for delivering an extract of Piper Methysticum, Ambrosios Kambouris, 15 October 2015
WO/2015/154140, Methods and compositions for delivering a probiotic, Ambrosios Kambouris, 15 October 2015
WO/2015/154139, Half-life extended Factor FVIIIa protein for prevention and treatment of bleeding and dosing regimens therefor, CSL Ltd, 15 October 2015
WO/2015/154126, Liposomal compound and compositions containing the compound, Jurlique International, 15 October 2015
WO/2015/149135, Process of manufacturing a stable dispersion for a dietary supplement, Sanofi Consumer Healthcare Australia, 8 October 2015
WO/2015/149131, Polymyxin derivatives as antimicrobial compounds, Monash University, 8 October 2015
WO/2015/149130, Immunological reagents and uses therefor, University of Queensland, 8 October 2015
WO/2015/149129, A prognostic assay for success of assisted reproductive technology, Hudson Institute of Medical Research, 8 October 2015
WO/2015/149105, Method for treating Chronic Lymphocytic Leukemia, Bionomics, 8 October 2015
WO/2015/143507, A dentifrice composition, Biodental Remin, 1 October 2015
WO/2015/143483, Method for improving feed efficiency in ruminants, Rivalea, 1 October 2015
WO/2015/139093, Stable gene transfer to proliferating cells, The Sydney Children's Hospitals Network, 24 September 2015
WO/2015/139085, Antimicrobial sanitizer compositions and their use, GFS Corporation Aus, 24 September 2015
WO/2015/139079, Anti-biofilm polymer, Newsouth Innovations, 24 September 2015
WO/2015/139074, Antimicrobial air sanitizer compositions and their use, Air Sanz, 24 September 2015
WO/2015/135024, Adjuvant therapy to standard of care (SOC) diuretic treatment, Madeleine Pharmaceuticals, 17 September 2015
WO/2015/135021, Nail polish remover, Rochelle Mercado, 17 September 2015
WO/2015/135016, Compositions that assist skin healing and/or maintain skin health, Ego Pharmaceuticals, 17 September 2015
WO/2015/131245, Sepsis treatment, La Trobe University, 11 September 2015
WO/2015/131231, Methods for using (-)-perhexiline, Adelaide Research & Innovation, 11 September 2015
WO/2015/131220, Composition and method for enhancing wound healing, Mark Tuffley, 11 September 2015
WO/2015/127512, Xanthone-rich plant extracts or compounds therefrom for modulating diseases of the central nervous system and related disorders, Deakin University, 3 September 2015
WO/2015/127501, Combination method for treatment of cancer, Viralytics, 3 September 2015
WO/2015/123734, Liquid carrier materials, University of Sydney, 27 August 2015
WO/2015/123728, Mycoplasma surface proteins and uses thereof, University of Technology, Sydney, 27 August 2015
WO/2015/123722, Inhibitors, Bionomics, 27 August 2015
WO/2015/123715, Ligand binding molecules and uses thereof, Vegenics, 27 August 2015
WO/2015/117206, Improved aptamers, Deakin University, 13 August 2015
WO/2015/117202, Functionalised benzopyran compounds and use thereof, Novogen, 13 August 2015
WO/2015/117201, Aptamer construct, Deakin University, 13 August 2015
WO/2015/117196, Antibacterial agents, University of Queensland, 13 August 2015
WO/2015/114062, New target for diabetes treatment and prevention, Universite De Strasbourg (France), INSERM (France), Vaxine, 6 August 2015
WO/2015/109367, Treatment of neoplasia, Sirtex Medical, 30 July 2015
WO/2015/109362, Method for reducing total gas production and/or methane production in a ruminant animal, Commonwealth Scientific and Industrial Research Organisation, 30 July 2015
WO/2015/107384, Pediculicidal composition, Hatchtech, 23 July 2015
WO/2015/106311, Cell surface prostate cancer antigen for diagnosis, Minomic International, 23 July 2015
WO/2015/095932, Stabilized stannous compositions, University of Melbourne, 2 July 2015
WO/2015/095925, Fusion proteins comprising Factor IX for prophylactic treatment of hemophilia and methods thereof, CSL Ltd, 2 July 2015
WO/2015/095918, Treatment of pain, Innovative Herbal Products, 2 July 2015
WO/2015/089590, Method of synthesis of silica vesicles and use thereof, University of Queensland, 25 June 2015
WO/2015/089585, Method of treating wounds, CSL Ltd, 25 June 2015
WO/2015/089575, Method of diagnosis and treatment, Paranta Biosciences, 25 June 2015
WO/2015/089559, Optimising bioavailability of intra vitreally injectable steroids, Eye Co, 25 June 2015
WO/2015/085373, Method of treatment of alopecia with monoterpenoids, Cellmid, 18 June 2015
WO/2015/085351, Pharmaconutrient composition, Newsouth Innovations, 18 June 2015
WO/2015/085348, Apparatus for producing therapeutically active proteins in blood and uses thereof, Cytokine Medical Australia, 18 June 2015
WO/2015/077845, Method of treating nephropathy, CSL Ltd, 4 June 2015
WO/2015/077844, Method of treating cancer, CSL Ltd, 4 June 2015
WO/2015/077831, Mikto-arm branched polymers, Commonwealth Scientific and Industrial Research Organisation, 4 June 2015
WO/2015/074124, Functionalised and substituted indoles as anti-cancer agents, Novogen, 28 May 2015
WO/2015/074123, Functionalised and substituted indoles as anti-cancer agents, Novogen, 28 May 2015
WO/2015/074115, Prevention and treatment of toxicosis, Meat & Livestock Australia with Charles Sturt University, 28 May 2015
WO/2015/074114, Stress management in livestock, Charles Sturt University, 28 May 2015
WO/2015/074103, Regimen and method for treatment of Type 2 Diabetes, Omniblend Innovation, 28 May 2015
WO/2015/074102, Composition and method for control of post-prandial glucose, Omniblend Innovation, 28 May 2015
WO/2015/071811, Dietary supplement for the treatment of acid reflux and gastro-oesophageal reflux disease (gord/gerd), KFSU, 21 May 2015
WO/2015/070280, Senescence and senescence associated secretory phenotype, Newsouth Innovations, 21 May 2015
WO/2015/066767, Therapeutic compositions, Yale University (US) with Flinders University, 14 May 2015
WO/2015/061860, Vasodilator formulation and method of use, ATP Institute, 7 May 2015
WO/2015/061856, Neuroprotective peptides, University of Western Australia, 7 May 2015
WO/2015/061847, Pain relief formulation and method of treatment, ATP Institute, 7 May 2015
WO/2015/061832, Pharmaceutical combinations for the treatment of cancer, Pitney Pharmaceuticals, 7 May 2015
WO/2015/061829, Cooling solution and methods of use, Magna Carta, 7 May 2015
WO/2015/061826, Novel scorpion toxin analogue and method for treating autoimmune diseases, Monash University, 7 May 2015
WO/2015/058258, Aβ modulating peptides, Alzhyme, 30 April 2015
WO/2015/054730, Compositions and methods of administering same, Palmaya, 23 April 2015
WO/2015/054718, Bone formation, University of Sydney, 23 April 2015
WO/2015/049589, Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma, EnGeneIC, 9 April 2015
WO/2015/048844, A method of producing exosomes, Paradigm Biopharmaceuticals, 9 April 2015
WO/2015/048842, Biomarkers for cell therapy, Cell Ideas, 9 April 2015
WO/2015/044395, Organometallic N-2-Cyano-1-Hydroxypropan-2-yl for use as anthelmintics, Universität Zürich (Switzerland) with University of Melbourne, 2 April 2015
WO/2015/042664, Novel immunotherapeutic composition and uses thereof, Aravax, 2 April 2015
WO/2015/042639, Method of extracting protein, Elastagen, 2 April 2015
WO/2015/039189, Modified anti-inflammatory proteins and method of use, James Cook University, 26 March 2015
WO/2015/039188, Anti-inflammatory proteins and methods of use, James Cook University, 26 March 2015
WO/2015/039187, Stem cell modulation II, University of Canberra, 26 March 2015
WO/2015/039173, Compositions for the treatment of hypertension and/or fibrosis, Vectus Biosystems, 26 March 2015
WO/2015/039172, Compositions for the treatment of hypertension and/or fibrosis, Vectus Biosystems, 26 March 2015
WO/2015/037747, Anticancer agent comprising aminoacetonitrile compound as active ingredient, Nihon Nohyaku Co. with Pitney Pharmaceuticals (owned by PharmAust), 19 March 2015
WO/2015/036986, Wound fluid elevated protease enzyme inhibition through camelid blood products, Patrick Prendergast, 19 March 2015
WO/2015/035475, Silica micro- and nano-capsules and methods for making them, University of Queensland, 19 March 2015
WO/2015/035474, Serological test, University of Melbourne, 19 March 2015
WO/2015/035460, Antisense oligomers and methods for treating SMN-related pathologies, University of Western Australia, 19 March 2015
WO/2015/035446, Macromolecules of dendrimer-platinum conjugates, Starpharma, 19 March 2015
WO/2015/035231, Antisense-induced exon2 inclusion in acid alpha-glucosidase, Sarepta Therapeutics (US) with Murdoch University, 12 March 2015
WO/2015/031958, Regulatory molecules, Garvan Institute of Medical Research, 12 March 2015
WO/2015/031950, Modified bacterial collagen-like proteins, Commonwealth Scientific and Industrial Research Organisation, 12 March 2015
WO/2015/027296, A method of treatment, University of Melbourne, 5 March 2015
WO/2015/024063, Formation of sub-nano metal particles, University of South Australia, 26 February 2015
WO/2015/024060, Immunoreceptor modulation for treating cancer and viral infections, Queensland Institute of Medical Research, 26 February 2015
WO/2015/024055, Separation of omega-3 fatty acids, Deakin University, 26 February 2015
WO/2015/024042, Immunoreceptor modulation for treating cancer and viral infections, Queensland Institute of Medical Research, 26 February 2015
WO/2015/021512, Sugar cane derived extracts and methods of treatment, The Product Makers, 19 February 2015
WO/2015/021508, Regeneration of damaged tissue, Elastagen, 19 February 2015
WO/2015/017901, Wheat having high levels of beta-glucan, Commonwealth Scientific and Industrial Research Organisation, 12 February 2015
WO/2015/017900, An antibody therapy for amyloid beta disease, St. Vincent's Institute of Medical Research, 12 February 2015
WO/2015/017888, Contaminant removal method, CSL Ltd, 12 February 2015
WO/2015/013739, Attenuated babesia vaccine, Griffith University, 5 February 2015
WO/2015/010166, Compositions and methods for dental mineralization, University of Melbourne, 29 January 2015
WO/2015/006833, A method for treating Type 1 Diabetes, St. Vincent's Institute of Medical Research, 22 January 2015
WO/2015/006803, UV absorbing compounds, compositions comprising same and uses thereof, Coral Sunscreen, 22 January 2015
WO/2015/000929, N-(1-Cyano-2-Hydroxy-1-Methyl-Ethyl)-4-(Trifluoromethylsulfanyl)Benzamide derivatives for use as nematocidal drugs, Universität Zürich (Switzerland) with University of Melbourne, 8 January 2015
WO/2015/000035, Method for preventing and/or treating chronic traumatic encephalopathy-IV, Pressura Neuro, 8 January 2015
WO/2015/000034, Method for preventing and/or treating chronic traumatic encephalopathy-III, Pressura Neuro, 8 January 2015
WO/2015/000033, Method for preventing and/or treating chronic traumatic encephalopathy-II, Pressura Neuro, 8 January 2015
WO/2015/000032, Method for preventing and/or treating chronic traumatic encephalopathy-I, Pressura Neuro, 8 January 2015
WO/2015/000022, Treatment and prevention of mastitis, Adelaide Research & Innovation, 8 January 2015
WO/2015/000014, Diagnosis and treatment of autoimmune diseases, Newsouth Innovations, 8 January 2015
WO/2015/000012, Radiolabelled material, Australian National University, 8 January 2015
WO/2014/205519, Antimicrobial compositions and methods of use, Dermcare-Vet, 31 December 2014
WO/2014/205516, Method of treating intracellular infection, Walter and Eliza Hall Institute of Medical Research, 31 December 2014
WO/2014/205511, Methods and compositions for modulating cancer stem cells, University of Canberra, 31 December 2014
WO/2014/205501, Il-21 binding proteins and uses thereof, Monash University, 31 December 2014
WO/2014/205491, Biological molecules and methods of use, Monash University, 31 December 2014
WO/2014/201525, Immunotherapy composition and use thereof, Ondek, 24 December 2014
WO/2014/201499, Johnson grass allergenic pollen proteins, encoding nucleic acids and methods of use, Queensland University of Technology, 24 December 2014
WO/2014/201492, Methods for the treatment of bladder cancer, Viralytics, 24 December 2014
WO/2014/197940, One step assembly of metal-polyphenol complexes for versatile film and particle engineering, University of Melbourne, 18 December 2014
WO/2014/197938, Combination therapy, Antisense Therapeutics, 18 December 2014
WO/2014/197937, Methods for detecting prostate cancer, University of South Australia, 18 December 2014
WO/2014/197934, Renal progenitor cells, University of Queensland, 18 December 2014
WO/2014/194364, Method of preventing or treating Bronchopulmonary Dysplasia (BPD) and Pulmonary Arterial Hypertension (PAH), Monash University, 11 December 2014
WO/2014/194362, Process for preparing Apolipoprotein A-I (APO A-I), CSL Ltd, 11 December 2014
WO/2014/190398, Inhibition of amyloid fibril formation, University of Melbourne, 4 December 2014
WO/2014/186843, Targeted delivery of drugs to the myometrium, Newcastle Innovation, 27 November 2014
WO/2014/186842, Antibodies and uses thereof, Monash University, 27 November 2014
WO/2014/186824, Treatment of neurological and other disorders, Palmaya, 27 November 2014
WO/2014/183168, Inhibitory propeptides, Oral Health Australia, 20 November 2014
WO/2014/183164, Dihydropyrrolones and their use as antimicrobial agents, Naresh Kumar, 20 November 2014
WO/2014/183147, Apricitabine and NRTI combination therapy, Avexa, 20 November 2014
WO/2014/180943, MCL-1 as critical regulator of Foxp3+ regulatory T cell survival, and use thereof to treat severe immune disorders, VIB (Belgium) with Katholieke Universiteit Leuven (Belgium) and Walter and Eliza Hall Institute of Medical Research, 13 November 2014
WO/2014/179845, Niacin formulation, Zeenar Enterprises, 13 November 2014
WO/2014/179843, Gluten enrichment of foods for Irritable Bowel Syndrome sufferers, Kerith Duncanson, 13 November 2014
WO/2014/179834, Compositions and methods for the treatment of tinnitus, Cell-Innovations, 13 November 2014
WO/2014/179831, Dosage projectile for remotely treating an animal, Smartvet, 13 November 2014
WO/2014/176636, Compounds and methods of treating infections, Neoculi, 6 November 2014
WO/2014/176634, Methods for treating bacterial infections, Neoculi, 6 November 2014
WO/2014/176632, Compositions and methods for treating microbiota-related psychotropic conditions and diseases, Thomas Borody, 6 November 2014
WO/2014/176394, Vitamin D receptor/SMAD genomic circuit gates fibrotic response, Salk Institute for Biological Studies (US) with University of Sydney, 30 October 2014
WO/2014/173873, Complex, CSL Ltd, 30 October 2014
WO/2014/172758, Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same, Terragen, 30 October 2014
WO/2014/172456, Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitors, Mayne Pharma with Hedgepath Pharmaceuticals (US), 23 October 2014
WO/2014/169356, Methods and compositions for wound healing, Qbiotics, 23 October 2014
WO/2014/169355, Method of viral inhibition, Monash University, 23 October 2014
WO/2014/169344, Methods and compositions for the treatment and/or prophylaxis of Clostridium Difficile associated disease, Immuron, 23 October 2014
WO/2014/165923, Composition for controlled delivery of bioactive agents, Commonwealth Scientific and Industrial Research Organisation, 16 October 2014
WO/2014/165916, Methods and compositions for inducing an immune response, Adelaide Research & Innovation, 16 October 2014
WO/2014/162303, Use of a dietary fibre supplement in a food formulation, Gratuk Technologies, 9 October 2014
WO/2014/161046, Methods of treating diseases characterized by excessive WNT signalling, Walter and Eliza Hall Institute of Medical Research, 9 October 2014
WO/2014/161037, Antibodies against human RYK and uses therefor, Peter MacCallum Cancer Institute, 9 October 2014
WO/2014/161036, Stimulus responsive substrates, University of South Australia, 9 October 2014
WO/2014/161031, Nanoparticles for drug delivery comprising albumin having a polymer chain coupled thereto, Newsouth Innovations, 9 October 2014
WO/2014/153624, Antibacterial compounds, University of Sydney, 2 October 2014
WO/2014/153620, Method for generating mature β-like cells, University of Western Australia, 2 October 2014
WO/2014/153614, Improved methods for osteoarthritis therapy, Cell-Innovations, 2 October 2014
WO/2014/140797, MicroRNA-based approach to treating malignant pleural mesothelioma, Asbestos Diseases Research Foundation, 18 September 2014
WO/2014/138824, Immune modulation, Sementis, 18 September 2014
WO/2014/138823, Compounds and uses thereof in the treatment/prevention of Gram-negative bacterial infections, Griffith University, 18 September 2014
WO/2014/138821, Improved air purifying apparatus, method & use of chemical substance, Air Sanz, 18 September 2014
WO/2014/138819, Agents that neutralize Il-3 signaling and uses thereof, CSL Ltd, 18 September 2014
WO/2014/138814, S-enantiomerically enriched compositions of beta blockers for treating Amyotrophic Lateral Sclerosis, Andrew Coats with Stefan Anker (Germany) and Jochen Springer (Germany), 18 September 2014
WO/2014/138812, Salts, co-crystals, and polymorphs of an anxiolytic compound, Bionomics, 18 September 2014
WO/2014/138806, Oxprenolol compositions for treating cancer, Andrew Coats with Stefan Anker (Germany) and Jochen Springer (Germany), 18 September 2014
WO/2014/138805, Anti Il-3r alpha agents and uses thereof, CSL Ltd, 18 September 2014
WO/2014/138802, Canrenoate compositions for treating cancer, Andrew Coats with Stefan Anker (Germany) and Jochen Springer (Germany), 18 September 2014
WO/2014/138796, Dosage regimen for therapeutic method, Madeleine Pharmaceuticals, 18 September 2014
WO/2014/138793, A method of isolating cells for therapy and prophylaxis, University of Queensland, 18 September 2014
WO/2014/138791, Transgenic non-human organisms with non-functional TSPO genes, Australian Nuclear Science and Technology Organisation, 18 September 2014
WO/2014/138772, A crystalline form of an anxiolytic compound, Bionomics, 18 September 2014
WO/2014/134689, Polymer conjugate for delivery of a bioactive agent, Polyactiva, 12 September 2014
WO/2014/132100, Mobilizing agents and uses therefor, Mater Medical Research Institute, 4 September 2014
WO/2014/128628, Cytoplasmic expression of Fab proteins, Affinity Biosciences, 28 August 2014
WO/2014/128465, 2-(Hetero)Aryl-Benzimidazole and Imidazopyridine derivatives as inhibitors of asparagine emethyl transferase, Cancer Therapeutics CRC, 28 August 2014
WO/2014/127418, Conjugate compound and uses of same, University of Queensland, 28 August 2014
WO/2014/124487, Ligand binding molecules and uses thereof, Vegenics, 21 August 2014
WO/2014/122638, Thalidomide and thalidomide analogues for the stimulation of stem cell factor, Patrick Prendergast, 14 August 2014
WO/2014/121343, Methods of treating microbial infections, including mastitis, Luoda Pharma, 14 August 2014
WO/2014/121342, Methods of treating topical microbial infections, Luoda Pharma, 14 August 2014
WO/2014/121325, Il-11r binding proteins and uses thereof, CSL Ltd, 14 August 2014
WO/2014/117220, Anti-CD83 antibodies and use thereof, Transbio with the University of Queensland and the University of California (US), 7 August 2014
WO/2014/117218, Slow release endodontic paste, Matthew Athanassiadis, 7 August 2014
WO/2014/113839, A method for improving the wellbeing of an animal using a composition including Vitamin K, Hubertus Regtop, 31 July 2014
WO/2014/113836, Treatment methods, Marinova, 31 July 2014
WO/2014/107763, Age-Related Macular Degeneration treatment, Benitec Biopharma, 17 July 2014
WO/2014/100857, Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy, Cell Ideas, 3 July 2014
WO/2014/100852, Inhibition of cancer growth and metastasis, Royal Melbourne Institute of Technology, 3 July 2014
WO/2014/100851, Improved antimicrobial compositions, Novapharm Research, 3 July 2014
WO/2014/094043, Methods of generating cells with multilineage potential, Newsouth Innovations, 26 June 2014
WO/2014/094041, Treatment of diseases involving mucin, Pitney Pharmaceuticals, 26 June 2014
WO/2014/094032, Polymorph, Oncology Research International, 26 June 2014
WO/2014/089620, Compositions and method for maintaining/improving cognitive function, Blackmores, 19 June 2014
WO/2014/089610, Scalable three-dimensional elastic construct manufacturing, Elastagen, 19 June 2014
WO/2014/085866, Use of miRNA antagonists for immune system modulation, treatment of bacterial infections and treatment of airways diseases, Newcastle Innovation, 12 June 2014
WO/2014/085851, Uses of Bacopa Monnieri extract, Soho Flordis International, 12 June 2014
WO/2014/085613, Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD2 inhibition, McCord Research (US) with Tom Karagiannis, 5 June 2014
WO/2014/082132, Microparticles comprising a probiotic, cross-linkable reagent, a denatured protein, polyol plasticiser and trehalose, Progel, 5 June 2014
WO/2014/082131, A microparticle composition comprising a probiotic, cross-linkable reagent and an emulsion containing a hydrophobic active, Progel, 5 June 2014
WO/2014/078912, Coating composition, Progel, 30 May 2014
WO/2014/078911, Compositions for the restoration of a fecal microbiota and methods for making and using them, Thomas Borody, 30 May 2014
WO/2014/078900, Anti-pathogenic methods, Hexima, 30 May 2014
WO/2014/078896, Complex-formation-modulating agents and uses therefor, Queensland University of Technology, 30 May 2014
WO/2014/078895, Omega-3 analogues, University of Sydney, 30 May 2014
WO/2014/078889, Improved inhibitors of GRB7, Monash University, 30 May 2014
WO/2014/075146, Macrocyclic compounds and uses thereof, Adelaide Research & Innovation, 22 May 2014
WO/2014/075137, Peptides incorporating amino-substituted lactams for treatment of retinopathy, Biodiem, 22 May 2014
WO/2014/075135, Transmucosal delivery of tocotrienol, Gordagen Pharmaceuticals, 22 May 2014
WO/2014/075125, Soluble mediator, Walter and Eliza Hall Institute of Medical Research, 22 May 2014
WO/2014/075124, Methods and compositions for the treatment and/or prevention of bowel disorders, Victoria University, 22 May 2014
WO/2014/072766, Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder, Tracey Seipel, 15 May 2014
WO/2014/072493, Pharmaceutical combination comprising a B-RAF inhibitor and a histone deacetylase inhibitor and their use in the treatment of proliferative diseases, Novartis with the Kolling Institute, 15 May 2014
WO/2014/071457, Dual action nitric oxide donors and their use as antimicrobial agents, Newsouth Innovations, 15 May 2014
WO/2014/071449, Neuroactive steroids and their use to facilitate neuroprotection, Goodchild Investments, 15 May 2014
WO/2014/071438, Modified polyphenols and modified polyphenol compositions, Cellarouge, 15 May 2014
WO/2014/066951, Dental compositions, Ozdent, 8 May 2014
WO/2014/066945, Genetically-modified probiotic for treatment of phenylketonuria, The Sydney Children's Hospital Network, 8 May 2014
WO/2014/066943, Reconstituted HDL formulation, CSL Ltd, 8 May 2014
WO/2014/066939, Novel immunotherapeutic molecules and uses thereof, Monash University, 8 May 2014
WO/2014/063205, Use of endocytosis inhibitors and antibodies for cancer therapy, University of Queensland, 1 May 2014
WO/2014/063199, Organic compounds, Akaal Pharma, 1 May 2014
WO/2014/063198, A radioisotope concentrator, Cyclopharm, 1 May 2014
WO/2014/063193, Substituted sulfone-containing tricyclic compounds and uses thereof, Walter and Eliza Hall Institute of Medical Research, 1 May 2014
WO/2014/063190, Method for reducing triglycerides, Deakin University, 1 May 2014
WO/2014/063189, Methods and products for preventing and/or treating a stress induced cardiomyopathy, Adelaide Research & Innovation, 1 May 2014
WO/2014/059489, Improved human herpesvirus immunotherapy, Queensland Institute of Medical Research, 24 April 2014
WO/2014/059484, Cancer therapy using miRNAs, University of Western Australia, 24 April 2014
WO/2014/059429, Small molecules inhibiting oncoprotein Myc, Health Research (US), Panacela Labs (US), Children's Cancer Institute, 17 April 2014
WO/2014/056039, Antimicrobial peptides modified for mammalian cell recognition and/or adhesion, Newsouth Innovations, 17 April 2014
WO/2014/056038, Novel flavonoid compounds and uses thereof, Armaron Bio, 17 April 2014
WO/2014/056026, Improved process for purifying growth factors from milk and products thereof, Murray Goulburn Co-Operative Co., 17 April 2014
WO/2014/056025, Improved process for purifying lactoferrin from milk and products thereof, Murray Goulburn Co-Operative Co., 17 April 2014
WO/2014/053014, Modulation of RNA activity and vascular permeability, Centenary Institute of Cancer Medicine and Cell Biology, 10 April 2014
WO/2014/052640, Novel AMPK agonist compositions and methods of use, Paul Plante (US) with Barbara Badenoch-Jones and Sebastian Marcuccio, 3 April 2014
WO/2014/049556, Neurotrophin-tyrosine kinase receptor signaling, University of Queensland, 3 April 2014
WO/2014/045283, Restoration of the CFTR function by splicing modulation, Hebrew University of Jerusalem (Israel) with University of Western Australia, 27 March 2014
WO/2014/043743, Viscous haemostatic compostions and method of treatment, Eupharma, 27 March 2014
WO/2014/043576, Method of treatment or prophylaxis of infections of the eye, Starpharma, 20 March 2014
WO/2014/041425, Daptomycin formulations and uses thereof, Hospira Australia, 20 March 2014
WO/2014/041349, Tetrahydropyran-4-Ylethylamino- or Tetrahydropyranyl-4-Ethyloxy-Pyrimidines or -Pyridazines as isoprenylcysteincarboxymethyl transferase inhibitors, Cancer Therapeutics CRC, 20 March 2014
WO/2014/040143, Method of treating cancer, Bruce Gray, 20 March 2014
WO/2014/036608, Methods and products for preventing and/or treating metastatic cancer, Adelaide Research & Innovation, 13 March 2014
WO/2014/036603, Uses of (-)-perhexiline, Adelaide Research & Innovation, 13 March 2014
WO/2014/036595, Compounds and methods for treating diseases or conditions associated with the central nervous system and/or neurite outgrowth, Bionomics, 13 March 2014
WO/2014/032099, Composition and method for bone growth, The Sydney Children's Hospitals Network, 6 March 2014
WO/2014/032082, Modified human rotaviruses and uses therefor, Murdoch Childrens Research Institute, 6 March 2014
WO/2014/028968, Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof, Peter MacCallum Cancer Institute, 27 February 2014
WO/2014/027199, FAK and FLT3 inhibitors, Cancer Therapeutics CRC, 20 February 2014
WO/2014/026243, VEGFR3 inhibitors, Cancer Therapeutics CRC, 20 February 2014
WO/2014/026242, VRGFR3 inhibitors, Cancer Therapeutics CRC, 20 February 2014
WO/2014/022886, A method, use, and dietary supplement composition for at least treating an atopic or non-atopic disorder in a patient, Karen Fischer, 13 February 2014
WO/2014/022879, Compounds for the treatment of mTOR pathway related diseases, Pitney Pharmaceuticals, 13 February 2014
WO/2014/019025, EpCAM aptamer for detection of cancer stem cells, Deakin University, 6 February 2014
WO/2014/019024, CD133 aptamers for detection of cancer stem cells, Deakin University, 6 February 2014
WO/2014/015388, A method for polishing albumin, CSL Ltd, 30 January 2014
WO/2014/015367, Polymers for siRNA delivery, University of Queensland, 30 January 2014
WO/2014/012147, Method of diagnosis and treatment, Latrobe University, 23 January 2014
WO/2014/008542, Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders, Brien Holden Vision Institute, 16 January 2014
WO/2014/008263, Paramyxovirus and methods of use, Henry M. Jackson Foundation for the Advancement of Military Medicine with CSIRO and the Queensland Department of Agriculture and Fisheries, 9 January 2014
WO/2014/007821, Compositions and methods for detecting anastomosis leakage, Empire Technology Development, 9 January 2014
WO/2014/005186, Methods for inhibiting neuron apoptosis and necrosis, Newsouth Innovations, 9 January 2014
WO/2014/005183, Treatment of inflammatory skin disorders, University of Sydney, 9 January 2014
WO/2014/005182, Phosphoinositide 3-Kinase (Pi3K) inhibitors, Monash University, 9 January 2014
WO/2014/000058, Method of treating glucose metabolism disorders, Garvan Institute of Medical Research, 3 January 2014
WO/2014/000042, Compositions and methods for modifying TGF-Β family ligands, Hudson Institute of Medical Research, 3 January 2014
WO/2014/000033, Polymer-NSAID conjugate, Polyactiva, 3 January 2014
WO/2014/000032, Phenyl amino pyrimidine bicyclic compounds and uses thereof, YM Biosciences Australia, 3 January 2014
WO/2014/000029, Compositions and methods for reducing frequency and/or severity of headache, Rusty Property Holdings, 3 January 2014
WO/2014/000027, Prevention and treatment of haematological conditions, University of Technology, Sydney, 3 January 2014
WO/2014/000026, Recombinant viral vectors and uses therefor, University of Canberra, 3 January 2014

New Zealand applicants

Here are the 87 PCT patent applications relevant to New Zealand's Life Sciences sector that have published since the start of 2014, for a publication rate of 2.4 applications per month:

WO/2016/190750, Beta-casein A2 and antioxidant capacity, A2 Milk Company, 1 December 2016
WO/2016/187067, Treatment of CNS disease with encapsulated inducible choroid plexus cells, Living Cell Technologies, 24 November 2016
WO/2016/186521, Haemolysis stabilising composition, Canterbury Scientific, 24 November 2016
WO/2016/185331, Surface treatments, Kode Biotech, 24 November 2016
WO/2016/182455, New treatment methods utilising lactose compositions, Ouchie Powder, 17 November 2016
WO/2016/178586, Collagen compositions and preparation and uses thereof, Auckland Uniservices, 10 November 201
WO/2016/163894, Control of parasitic infection in animals, Cropmark Seeds, 13 October 2016
WO/2016/153363, Water-soluble mussel extract, New Zealand Institute for Plant and Food Research, 29 September 2016
WO/2016/153362, Water-soluble paua extract, New Zealand Institute for Plant and Food Research, 29 September 2016
WO/2016/140581, Ophthalmic compositions and methods of use therefor, Auckland Uniservices, 9 September 2016
WO/2016/130024, Endolysin expression platform, Supreme Biotechnologies with University College London (UK), 18 August 2016
WO/2016/103192, Amino acid and peptide conjugates and uses thereof, Margaret Brimble, 30 June 2016
WO/2016/090174, Kinase inhibitor prodrug for the treatment of cancer, Auckland Uniservices, 9 June 2016
WO/2016/085356, Gold kiwifruit compositions and methods of preparation and use therefor, Anagenix, 2 June 2016
WO/2016/080850, Multivalent ligand-lipid constructs, Kode Biotech, 26 May 2016
WO/2016/080846, Antibacterial compounds, Janine Copp and David Ackerley, 26 May 2016
WO/2016/072863, Antimicrobial surface treatment, Kode Biotech, 12 May 2016
WO/2016/029191, Channel modulators, Auckland Uniservices, 25 February 2016
WO/2016/024870, Cancer diagnosis and therapy, Gillies McIndoe Research Institute, 18 February 2016
WO/2016/024233, Inhibitors of Tryptophan Dioxygenases (IDO1 and TDO) and their use in therapy, Auckland Uniservices, 18 February 2016
WO/2016/010440, Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health, Manuka Health New Zealand, 21 January 2016
WO/2016/009246, Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment, Patrick Casey and Murray Hoare, 21 January 2016
WO/2015/199555, Polymers for coating nanoparticles, Victoria Link, 30 December 2015
WO/2015/194970, Method of treating or preventing Multiple Sclerosis using one or more neural regeneration peptides, CuroNZ, 23 December 2015
WO/2015/187040, Amino sphingoglycolipid analogues, Regan Anderson et. al., 10 December 2015
WO/2015/183106, Use of allene oxide synthase for semen preservation and assisted reproduction, Pacific Brands, 3 December 2015
WO/2015/170993, A Matrix-Metalloproteinase (MMP) inhibitory extract and methods of use thereof, Comvita, 12 November 2015
WO/2015/147655, Stable veterinary anthelmintic formulations, Donaghys, 1 October 2015
WO/2015/145269, Method for the treatment of damaged tissue, Patrick Casey, 1 October 2015
WO/2015/119512, Polymer particles and uses thereof, Bernd Rehm, 13 August 2015
WO/2015/118468, Ectoparasite formulation, Argenta, 13 August 2015
WO/2015/095227, Peptidomimetic compounds and antibody-drug conjugates thereof, Genentech (US) with University of Auckland, 25 June 2015
WO/2015/084188, Method of treating or preventing epilepsy or seizures using one or more neural regeneration peptides, CuroNZ, 11 June 2015
WO/2015/084187, Functionalizing nanofibres, Kode Biotech, 11 June 2015
WO/2015/084181, Furo[3,4-B]pyran compounds and pharmaceutical uses, Victoria Link, 11 June 2015
WO/2015/080603, Glycoproteins, Antony Fairbanks, 4 June 2015
WO/2015/053636, Veterinary formulations and methods, Gary Harrison, 16 April 2015
WO/2015/041544, Bee venom compositions and uses, Honeylab, 26 March 2015
WO/2015/033211, High osteocalcin microcrystalline hydroxyapatite for calcium supplement, Waitaki Biosciences, 12 March 2015
WO/2015/030609, Anti-inflammatory compositions, methods and uses thereof, Apimed Medical Honey, 5 March 2015
WO/2015/030605, Honey compositions, Honeylab, 5 March 2015
WO/2015/028892, Reaction platform and method for making pollen based materials in combination with beeswax and uses thereof, Decima Health, 5 March 2015
WO/2015/026245, Beta-casein A2 and blood glucose levels, The A2 Milk Company, 26 February 2015
WO/2015/013397, Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders, Neuren Pharmaceuticals, 29 January 2015
WO/2015/008166, Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment, Patrick Casey and Murray Hoare, 22 January 2015
WO/2015/005804, Beta-casein A2 and reducing or preventing symptoms of lactose intolerance, The A2 Milk Company, 15 January 2015
WO/2014/209136, Anti-viral compound and composition, Forest Herbs Research, 31 December 2014
WO/2014/200363, Sphingoglycolipid analogues, Victoria Link, 18 December 2014
WO/2014/193248, Beta-casein A2 and prevention of inflammation of the bowel, The A2 Milk Company, 4 December 2014
WO/2014/189392, Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms, Breathe Easy, 27 November 2014
WO/2014/189386, Method for supervising consumption of a medical food comprising Eicosapentaenoic Acid for prevention and/or management of a disease or condition, Photonz Corporation, 27 November 2014
WO/2014/185792, Oral healthcare product, Alequident, 20 November 2014
WO/2014/171842, Biocompatible encapsulation system, Living Cell Technologies, 23 October 2014
WO/2014/167530, Cannabinoid compounds, Matthew Bowden and James Williamson, 16 October 2014
WO/2014/163513, Therapeutic compositions and uses thereof, Manuka Health New Zealand, 9 October 2014
WO/2014/163512, Therapeutic compositions comprising extracts of propolis and uses thereof, Manuka Health New Zealand, 9 October 2014
WO/2014/158033, Stabilized Vitamin D formulations, API Consumer Brands, 2 October 2014
WO/2014/153514, Contraceptive vaccines for mammals, Patrick Casey and Irwin Liu, 25 September 2014
WO/2014/142675, Nanofibre and bioactive compositions and related methods, Active Fibres, 18 September 2014
WO/2014/141223, Chewable formulation, Argenta, 18 September 2014
WO/2014/137229, Neural regeneration peptides and uses therefor, CuroNZ, 12 September 2014
WO/2014/132227, Transdermal formulations, Argenta, 4 September 2014
WO/2014/129914, Methods of treatment, Auckland Uniservices, 28 August 2014
WO/2014/120021, A combination medicament comprising phenylephrine and paracetamol, AFT Pharmaceuticals, 7 August 2014
WO/2014/116121, Assembly of micelle aggregates of surfactant micelles and silver nanoparticles and use as antibacterial agent, Otago Innovation, 31 July 2014
WO/2014/098624, Veterinary injectable formulations, Alleva Animal Health, 26 June 2014
WO/2014/098623, Injectable eprinomectin formulation and anthelmintic use thereof, Alleva Animal Health, 26 June 2014
WO/2014/098619, Transdermal parasiticidal formulations, Donaghys, 26 June 2014
WO/2014/088432, Conjugate compounds, Callaghan Innovation, 12 June 2014
WO/2014/085480, Treatment of Autism Spectrum Disorders using Glycyl-L-2-Methylprolyl-L-Glutamic Acid, Neuren Pharmaceuticals, 5 June 2014
WO/2014/084744, Saccharide dendritic cluster compounds as inhibitors of BACE-1, The University Of Liverpool (UK) with Victoria Link, 5 June 2014
WO/2014/073989, Salt and polymorphic forms of (3R,4S)-L-((4-Amino-5H-Pyrrolo[3,2-D]Pyrimidin-7-Yl)Methyl)-4(Methylthiomethyl)Pyrodin-3-Ol(Mtdia), Victoria Link, 15 May 2014
WO/2014/057414, Ketamine derivatives, Auckland Uniservices, 17 April 2014
WO/2014/051442, Veterinary pharmaceutical formulations and methods, Nexan Corporation, 3 April 2014
WO/2014/051440, Ectoparasitic treatment method and composition, Bayer New Zealand, 3 April 2014
WO/2014/043046, Treatment and prevention of P. Aeruginosa infections using coformycin analogs, Albert Einstein College of Medicine of Yeshiva University (US) with Callaghan Innovation, 20 March 2014
WO/2014/038963, Dendrimer scaffolds for pharmaceutical use, Victoria Link, 13 March 2014
WO/2014/038962, Methods and uses of an extract from olive leaf in management of Type 2 Diabetes, Apimed Medical Honey, 13 March 2014
WO/2014/030142, Nitroimidazole compounds and their use in cancer therapy, Auckland Uniservices, 27 February 2014
WO/2014/027899, NTproCNP as a biomarker of vascular disorders and pregnancy complication, Otago Innovation, 20 February 2014
WO/2014/025842, Treatment of Helicobacter Pylori infections, Albert Einstein College of Medicine of Yeshiva University (US) with Callaghan Innovation, 13 February 2014
WO/2014/017928, Organic compounds, Callaghan Innovation, 30 January 2014
WO/2014/017927, Method of treating optic nerve damage, ophthalmic ischemia or ophthalmic reperfusion injury, CuroNZ, 30 January 2014
WO/2014/014364, Injectable antibiotic formulations and their methods of use, Bayer New Zealand, 23 January 2014
WO/2014/014363, Injectable antibiotic formulations and their methods of use, Bayer New Zealand, 23 January 2014
WO/2014/007661, Methods for determining personalized treatment compositions for prostate cancer and breast cancer, Caldera Health, 9 January 2014.
WO/2014/007650, Compounds and methods for selective imaging and/or ablation, Auckland Uniservices, 9 January 2014